Greenwich LifeSciences, Inc. (GLSI)
16.03
+0.55
(+3.55%)
USD |
NASDAQ |
Oct 23, 16:00
16.07
+0.04
(+0.25%)
After-Hours: 20:00
Greenwich LifeSciences Market Cap : 235.29M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 235.29M |
| October 22, 2026 | 227.22M |
| October 21, 2026 | 243.22M |
| October 20, 2026 | 238.37M |
| October 19, 2026 | 223.26M |
| October 16, 2026 | 213.57M |
| October 15, 2026 | 224.87M |
| October 14, 2026 | 226.04M |
| October 13, 2026 | 227.51M |
| October 12, 2026 | 260.83M |
| October 09, 2026 | 242.63M |
| October 08, 2026 | 222.23M |
| October 07, 2026 | 225.90M |
| October 06, 2026 | 231.77M |
| October 05, 2026 | 248.21M |
| October 02, 2026 | 249.24M |
| October 01, 2026 | 254.67M |
| September 30, 2026 | 264.94M |
| September 29, 2026 | 269.79M |
| September 28, 2026 | 272.87M |
| September 25, 2026 | 267.44M |
| September 24, 2026 | 265.68M |
| September 23, 2026 | 257.02M |
| September 22, 2026 | 285.93M |
| September 21, 2026 | 272.94M |
| Date | Value |
|---|---|
| September 18, 2026 | 278.74M |
| September 17, 2026 | 269.93M |
| September 16, 2026 | 229.42M |
| September 15, 2026 | 236.17M |
| September 14, 2026 | 235.59M |
| September 11, 2026 | 226.78M |
| September 10, 2026 | 221.05M |
| September 09, 2026 | 220.61M |
| September 08, 2026 | 233.38M |
| September 04, 2026 | 234.12M |
| September 03, 2026 | 229.42M |
| September 02, 2026 | 231.03M |
| September 01, 2026 | 220.32M |
| August 31, 2026 | 219.44M |
| August 28, 2026 | 230.01M |
| August 27, 2026 | 274.92M |
| August 26, 2026 | 267.58M |
| August 25, 2026 | 272.87M |
| August 24, 2026 | 258.04M |
| August 21, 2026 | 244.69M |
| August 20, 2026 | 224.72M |
| August 19, 2026 | 254.52M |
| August 18, 2026 | 253.35M |
| August 17, 2026 | 255.11M |
| August 14, 2026 | 246.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| PEG Ratio | -0.6441 |
| Price to Book Value | 75.49 |
| Price | 16.03 |
| Earnings Yield | -9.46% |
| PEGY Ratio | -0.6441 |